Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.4605
+0.0045 (0.99%)
Mar 17, 2026, 10:15 AM EDT - Market open

Gossamer Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
107205206205857714
Market Cap Growth
-61.76%-0.34%0.38%-76.09%19.93%-25.85%
Enterprise Value
128.2112.39106.81160.36713.88381.84
Last Close Price
0.460.900.912.1711.319.67
PE Ratio
--3.62-0.77-0.80-3.61-2.72
PS Ratio
2.401.79----
PB Ratio
-6.953.2816.977.052.23
P/TBV Ratio
-1.276.942.2215.206.972.07
P/FCF Ratio
--59.11-1.29-1.09-4.50-4.02
P/OCF Ratio
--59.11-1.29-1.10-4.54-4.05
EV/Sales Ratio
2.910.98----
EV/EBITDA Ratio
--2.02-0.60-0.75-3.38-1.66
EV/EBIT Ratio
--1.88-0.58-0.73-3.30-1.63
EV/FCF Ratio
--32.41-0.67-0.86-3.75-2.15
Debt / Equity Ratio
-2.456.853.1517.481.500.56
Debt / EBITDA Ratio
-1.02-3.62-1.17-1.04-0.86-0.78
Debt / FCF Ratio
-1.27-58.22-1.31-1.19-0.96-1.01
Net Debt / Equity Ratio
-0.26-3.14-1.39-2.73-1.18-1.04
Net Debt / EBITDA Ratio
-0.111.660.490.150.681.45
Net Debt / FCF Ratio
-0.1426.700.550.180.751.87
Asset Turnover
0.170.370000
Quick Ratio
3.056.665.745.198.1613.26
Current Ratio
3.286.885.945.328.3213.51
Return on Equity (ROE)
735.92%-122.54%-480.50%-343.53%-105.85%-72.30%
Return on Assets (ROA)
-75.23%-19.41%-62.89%-70.96%-48.95%-48.44%
Return on Invested Capital (ROIC)
2356.28%384.35%810.60%1034.39%1299.41%1955.39%
Return on Capital Employed (ROCE)
-95.73%-22.59%-76.01%-82.95%-53.72%-52.55%
Earnings Yield
-147.96%-27.64%-129.32%-124.88%-27.67%-36.71%
FCF Yield
-150.19%-1.69%-77.38%-91.48%-22.23%-24.90%
Buyback Yield / Dilution
-0.31%-0.53%-98.09%-59.98%-0.39%-16.65%
Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q